STEVANATO GROUP SPA O.N. (87N) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.063x

Based on the latest financial reports, STEVANATO GROUP SPA O.N. (87N) has a cash flow conversion efficiency ratio of 0.063x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€94.11 Million ≈ $110.02 Million USD) by net assets (€1.49 Billion ≈ $1.74 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

STEVANATO GROUP SPA O.N. - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how STEVANATO GROUP SPA O.N.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of STEVANATO GROUP SPA O.N. for a breakdown of total debt and financial obligations.

STEVANATO GROUP SPA O.N. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of STEVANATO GROUP SPA O.N. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Prima Andalan Mandiri Tbk PT
JK:MCOL
0.113x
Drägerwerk AG & Co. KGaA
XETRA:DRW8
0.050x
VITZROCELL Co.Ltd
KQ:082920
0.016x
Guangzhou KingTeller Technology Co Ltd
SHE:002177
0.006x
Zhejiang Shengyang Science
SHG:603703
0.010x
Shanxi Zhendong Pharmaceutical
SHE:300158
-0.055x
DNA Link Inc
KQ:127120
-0.030x
Shinry Technologies Co Ltd Class A
SHE:300745
0.147x

Annual Cash Flow Conversion Efficiency for STEVANATO GROUP SPA O.N. (2021–2025)

The table below shows the annual cash flow conversion efficiency of STEVANATO GROUP SPA O.N. from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of STEVANATO GROUP SPA O.N..

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €1.49 Billion
≈ $1.74 Billion
€286.08 Million
≈ $334.45 Million
0.192x +73.50%
2024-12-31 €1.40 Billion
≈ $1.64 Billion
€155.78 Million
≈ $182.12 Million
0.111x +19.41%
2023-12-31 €1.13 Billion
≈ $1.32 Billion
€105.21 Million
≈ $123.00 Million
0.093x -10.46%
2022-12-31 €995.91 Million
≈ $1.16 Billion
€103.31 Million
≈ $120.78 Million
0.104x -34.52%
2021-12-31 €841.66 Million
≈ $983.99 Million
€133.34 Million
≈ $155.88 Million
0.158x --

About STEVANATO GROUP SPA O.N.

F:87N Germany Medical Instruments & Supplies
Market Cap
$831.06 Million
€710.85 Million EUR
Market Cap Rank
#9961 Global
#1190 in Germany
Share Price
€14.30
Change (1 day)
+2.88%
52-Week Range
€11.40 - €23.60
All Time High
€32.30
About

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprisi… Read more